_version_ 1784748524322160640
author Girerd, Nicolas
Von Hunolstein, Jean‐Jacques
Pellicori, Pierpaolo
Bayés‐Genís, Antoni
Jaarsma, Tiny
Lund, Lars H.
Bilbault, Pascal
Boivin, Jean‐Marc
Chouihed, Tahar
Costa, Jérôme
Eicher, Jean‐Christophe
Fall, Estelle
Kenizou, David
Maillier, Bruno
Nazeyrollas, Pierre
Roul, Gérald
Zannad, Noura
Rossignol, Patrick
Seronde, Marie‐France
author_facet Girerd, Nicolas
Von Hunolstein, Jean‐Jacques
Pellicori, Pierpaolo
Bayés‐Genís, Antoni
Jaarsma, Tiny
Lund, Lars H.
Bilbault, Pascal
Boivin, Jean‐Marc
Chouihed, Tahar
Costa, Jérôme
Eicher, Jean‐Christophe
Fall, Estelle
Kenizou, David
Maillier, Bruno
Nazeyrollas, Pierre
Roul, Gérald
Zannad, Noura
Rossignol, Patrick
Seronde, Marie‐France
author_sort Girerd, Nicolas
collection PubMed
description
format Online
Article
Text
id pubmed-9288781
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92887812022-07-19 Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction Girerd, Nicolas Von Hunolstein, Jean‐Jacques Pellicori, Pierpaolo Bayés‐Genís, Antoni Jaarsma, Tiny Lund, Lars H. Bilbault, Pascal Boivin, Jean‐Marc Chouihed, Tahar Costa, Jérôme Eicher, Jean‐Christophe Fall, Estelle Kenizou, David Maillier, Bruno Nazeyrollas, Pierre Roul, Gérald Zannad, Noura Rossignol, Patrick Seronde, Marie‐France ESC Heart Fail Editorial John Wiley and Sons Inc. 2022-04-15 /pmc/articles/PMC9288781/ /pubmed/35429120 http://dx.doi.org/10.1002/ehf2.13929 Text en © 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Editorial
Girerd, Nicolas
Von Hunolstein, Jean‐Jacques
Pellicori, Pierpaolo
Bayés‐Genís, Antoni
Jaarsma, Tiny
Lund, Lars H.
Bilbault, Pascal
Boivin, Jean‐Marc
Chouihed, Tahar
Costa, Jérôme
Eicher, Jean‐Christophe
Fall, Estelle
Kenizou, David
Maillier, Bruno
Nazeyrollas, Pierre
Roul, Gérald
Zannad, Noura
Rossignol, Patrick
Seronde, Marie‐France
Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction
title Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction
title_full Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction
title_fullStr Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction
title_full_unstemmed Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction
title_short Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction
title_sort therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288781/
https://www.ncbi.nlm.nih.gov/pubmed/35429120
http://dx.doi.org/10.1002/ehf2.13929
work_keys_str_mv AT girerdnicolas therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction
AT vonhunolsteinjeanjacques therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction
AT pellicoripierpaolo therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction
AT bayesgenisantoni therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction
AT jaarsmatiny therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction
AT lundlarsh therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction
AT bilbaultpascal therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction
AT boivinjeanmarc therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction
AT chouihedtahar therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction
AT costajerome therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction
AT eicherjeanchristophe therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction
AT fallestelle therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction
AT kenizoudavid therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction
AT maillierbruno therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction
AT nazeyrollaspierre therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction
AT roulgerald therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction
AT zannadnoura therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction
AT rossignolpatrick therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction
AT serondemariefrance therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction
AT therapeuticinertiainthepharmacologicalmanagementofheartfailurewithreducedejectionfraction